Medicine composition for treating hepatopathy and preparing method thereof

Abstract

The invention discloses a medicine composition for treating hepatopathy and a preparing method thereof. The medicine composition for treating hepatopathy is prepared from oriental grape roots, oat, pedicularis megalochila, iris dichotoma, schoepfia chinensis, common yellowflax leaves, sinopimelodendron kwangsiense, corydalis delavayi, aralia mandshurica, saussurea nigrescens, eryngium foetidum, bauhinia variegata, cynolgossum officinale, adinandra mellettii, marsdenia tinctoria, meehania urticifolia, eriophyton wallichii and colquhounia coccinea. According to the medicine composition, the traditional Chinese medicinal materials are reasonably matched, medicine ingredients generate the synergetic function accordingly, the medicine composition can have the treatment effect on various kinds of hepatopathy, and injured hepatic cells can be repaired; the traditional Chinese medicinal ingredients such as scutellaria baicalensis and coptis chinensis with the anti-inflammation effect are combined, the traditional Chinese medicinal materials can achieve the synergetic effect, the treatment effect on the hepatopathy diseases is improved, repairing of the hepatic cells is promoted, and immunity is improved; vitamins C, vitamins B and penicillin are added, nutrients and energy are provided for the hepatic cells, and then the aim of rapidly repairing the hepatic cells is achieved.

Description

technical field [0001] The invention relates to the technical field of medicines for liver diseases, in particular to a pharmaceutical composition for treating liver diseases and a preparation method thereof. Background technique [0002] Hepatitis, liver cirrhosis, and hepatic ascites are common liver diseases, which seriously endanger people's health. Due to the complex etiology of its disease, if it is not treated in time or the treatment effect is not good, the condition will worsen. At present, the medical treatment of the above-mentioned liver diseases, especially the treatment of hepatitis B, etc., mainly adopts antiviral therapy. Patients who can receive formal antiviral treatment are still relatively limited, so most patients can only prevent the further development of the disease by anti-inflammatory and liver protection. [0003] Based on this, some researchers are also engaged in the research on the use of traditional Chinese medicine compositions for the treat...

AI Technical Summary

Problems solved by technology

Due to the complex etiology of the disease, if it is not treated in time or the treatment effect is not good, the condition will worsen

At present, the medical treatment of the above-mentioned liver diseases, especially the treatment of hepatitis B, etc., mainly adopts antiviral therapy. Patients who can receive formal antiviral treatment are still relatively limited, so most patients can only prevent the further development of the disease by anti-inflammatory and liver protection

[0003] Based on this, some researchers are also engaged in the research on the use of traditional Chinese medicine compositions for the treatment of liver diseases, such as "A Chinese Medicine for Treating Hepatitis, Cirrhosis, and Hepatic Ascites" with the patent number 201310044232.2. A new way of thinking; however, the demand for liver disease treatment drugs is still relatively large, and it is only limited to these kinds of Chinese medicinal materials for treatment, which makes the cost of liver disease treatment with traditional Chinese medicine higher, and even the treatment cycle is longer. The effect is not obvious